I've been watching Summit Therapeutics for a while with their Phase II ivonescimab trial. Yesterday the OS data came out for the trial with the result being 0.66 which is really promising for future development of the treatment. But yet today the stock is down 11% on market opening. I understand that "sell the news" could be a factor and that SMMT have not had the best earnings but I thought surely this news would drive a boost in the price.